Squarepoint’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Squarepoint’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,449	Closed	-$167K	–	4802
2024 Q1	$167K	Sell	19,449 -1,165	-6%	-$5.56K	﹤0.01%	3672
2023 Q4	$72.2K	Buy	+20,614	New	+$72.5K	﹤0.01%	3805

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

Squarepoint's TCON Position: Q2 2024 in Review

Squarepoint sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 19,449 shares — an estimated $167K sold.

Squarepoint first reported a position in TCON in Q4 2023 and held it in 2 quarters. The position peaked at $167K in Q1 2024. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

Squarepoint reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Squarepoint sold 19,449 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $167K.
Squarepoint first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Squarepoint's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $167K in Q1 2024.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.